Published in Biotech Business Week, October 13th, 2003
Gerard E. Puorro, Candela's president and CEO, commented: "We are very pleased to gain this additional clearance from the FDA. The treatment of wrinkles and other cosmetic procedures is growing at a tremendous rate. Our involvement in these markets outlines our path for growth in the coming years. This represents our fourth FDA approval for Smoothbeam. Adding multiple indications to our lasers makes purchasing a laser an attractive financial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.